Anaptysbio (ANAB) Interest Expenses (2016 - 2019)
Anaptysbio posted quarterly Interest Expenses of $200000.0 for Q4 2019, down 45.21% year-on-year from $365000.0 in Q4 2018, and down 16.67% on a QoQ basis from $240000.0 in Q3 2019.
Anaptysbio (ANAB) has 4 years of Interest Expenses data on file, last reported at $200000.0 in Q4 2019.
- For the quarter ending Q4 2019, Interest Expenses fell 45.21% year-over-year to $200000.0; the trailing twelve-month figure through Sep 2020 stood at $200000.0 (down 83.42% YoY), and the FY2019 full-year result was $1.0 million, down 36.99% from the prior year.
- Interest Expenses for Q4 2019 stood at $200000.0, down from $240000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $456000.0 in Q4 2017 and bottomed at $111000.0 in Q4 2016.
- The 4-year median for Interest Expenses is $342500.0 (2018), against an average of $307875.0.
- The widest annual swing landed in 2017, when Interest Expenses surged 310.81%; it then tumbled 45.21% in 2019.
- A 4-year view of Interest Expenses shows it stood at $111000.0 in 2016, then soared by 310.81% to $456000.0 in 2017, then slipped by 19.96% to $365000.0 in 2018, then plunged by 45.21% to $200000.0 in 2019.
- The last three Interest Expenses figures came in at $200000.0 (Q4 2019), $240000.0 (Q3 2019), and $281000.0 (Q2 2019), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 22,854.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -5.50 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 61,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -332,000.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 12.90 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 69.29 Mn |
| 10 | Anaptysbio | 1.60 Bn | 1.31 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 200,000.00 |
| Dec 31, 2019 | 200,000.00 |
| Sep 30, 2019 | 240,000.00 |
| Sep 30, 2019 | 240,000.00 |
| Jun 30, 2019 | 281,000.00 |
| Jun 30, 2019 | 281,000.00 |
| Mar 31, 2019 | 320,000.00 |
| Mar 31, 2019 | 320,000.00 |
| Dec 31, 2018 | 365,000.00 |
| Dec 31, 2018 | 365,000.00 |
| Sep 30, 2018 | 400,000.00 |
| Sep 30, 2018 | 400,000.00 |
| Jun 30, 2018 | 436,000.00 |
| Jun 30, 2018 | 436,000.00 |
| Mar 31, 2018 | 451,000.00 |
| Mar 31, 2018 | 451,000.00 |
| Dec 31, 2017 | 456,000.00 |
| Dec 31, 2017 | 456,000.00 |
| Sep 30, 2017 | 452,000.00 |
| Sep 30, 2017 | 452,000.00 |
| Jun 30, 2017 | 439,000.00 |
| Jun 30, 2017 | 439,000.00 |
| Mar 31, 2017 | 428,000.00 |
| Mar 31, 2017 | 428,000.00 |
| Dec 31, 2016 | 111,000.00 |
| Dec 31, 2016 | 111,000.00 |
| Sep 30, 2016 | 116,000.00 |
| Sep 30, 2016 | 116,000.00 |
| Jun 30, 2016 | 116,000.00 |
| Jun 30, 2016 | 116,000.00 |
| Mar 31, 2016 | 115,000.00 |
| Mar 31, 2016 | 115,000.00 |